Eledon Pharmaceuticals Stock Forward View - Simple Regression
| ELDN Stock | USD 2.09 0.04 1.88% |
Eledon Stock outlook is based on your current time horizon. Although Eledon Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Eledon Pharmaceuticals' systematic risk associated with finding meaningful patterns of Eledon Pharmaceuticals fundamentals over time.
As of today the rsi of Eledon Pharmaceuticals' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.25) | EPS Estimate Current Year (0.68) | EPS Estimate Next Year (0.94) | Wall Street Target Price 8 | EPS Estimate Current Quarter (0.25) |
Using Eledon Pharmaceuticals hype-based prediction, you can estimate the value of Eledon Pharmaceuticals from the perspective of Eledon Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Eledon Pharmaceuticals using Eledon Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Eledon using crowd psychology based on the activity and movement of Eledon Pharmaceuticals' stock price.
Eledon Pharmaceuticals Implied Volatility | 1.22 |
Eledon Pharmaceuticals' implied volatility exposes the market's sentiment of Eledon Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Eledon Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Eledon Pharmaceuticals stock will not fluctuate a lot when Eledon Pharmaceuticals' options are near their expiration.
The Simple Regression forecasted value of Eledon Pharmaceuticals on the next trading day is expected to be 2.17 with a mean absolute deviation of 0.13 and the sum of the absolute errors of 8.26. Eledon Pharmaceuticals after-hype prediction price | USD 2.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Eledon Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Eledon contract
Based on the Rule 16, the options market is currently suggesting that Eledon Pharmaceuticals will have an average daily up or down price movement of about 0.0763% per day over the life of the 2026-05-15 option contract. With Eledon Pharmaceuticals trading at USD 2.09, that is roughly USD 0.001594 . If you think that the market is fully incorporating Eledon Pharmaceuticals' daily price movement you should consider acquiring Eledon Pharmaceuticals options at the current volatility level of 1.22%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 Eledon Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Eledon Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Eledon Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Eledon Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Eledon Pharmaceuticals' open interest, investors have to compare it to Eledon Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Eledon Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Eledon. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Eledon Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Eledon price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eledon using various technical indicators. When you analyze Eledon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Eledon Pharmaceuticals Simple Regression Price Forecast For the 12th of February 2026
Given 90 days horizon, the Simple Regression forecasted value of Eledon Pharmaceuticals on the next trading day is expected to be 2.17 with a mean absolute deviation of 0.13, mean absolute percentage error of 0.03, and the sum of the absolute errors of 8.26.Please note that although there have been many attempts to predict Eledon Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Eledon Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Eledon Pharmaceuticals Stock Forecast Pattern
| Backtest Eledon Pharmaceuticals | Eledon Pharmaceuticals Price Prediction | Research Analysis |
Eledon Pharmaceuticals Forecasted Value
In the context of forecasting Eledon Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Eledon Pharmaceuticals' downside and upside margins for the forecasting period are 0.02 and 6.77, respectively. We have considered Eledon Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Eledon Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Eledon Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.3034 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1332 |
| MAPE | Mean absolute percentage error | 0.0753 |
| SAE | Sum of the absolute errors | 8.2558 |
Predictive Modules for Eledon Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eledon Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eledon Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Eledon Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Eledon Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eledon Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Eledon Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Eledon Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Eledon Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eledon Pharmaceuticals' historical news coverage. Eledon Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.10 and 6.75, respectively. We have considered Eledon Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Eledon Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of Eledon Pharmaceuticals is based on 3 months time horizon.
Eledon Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Eledon Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eledon Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eledon Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.39 | 4.61 | 0.00 | 0.01 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.09 | 2.09 | 0.00 |
|
Eledon Pharmaceuticals Hype Timeline
Eledon Pharmaceuticals is currently traded for 2.09. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Eledon is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.39%. %. The volatility of related hype on Eledon Pharmaceuticals is about 14870.97%, with the expected price after the next announcement by competition of 2.10. About 57.0% of the company shares are held by institutions such as insurance companies. The book value of Eledon Pharmaceuticals was currently reported as 1.52. The company has Price/Earnings To Growth (PEG) ratio of 0.01. Eledon Pharmaceuticals recorded a loss per share of 1.3. The entity last dividend was issued on the 5th of October 2020. The firm had 1:18 split on the 5th of October 2020. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Historical Fundamental Analysis of Eledon Pharmaceuticals to cross-verify your projections.Eledon Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Eledon Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Eledon Pharmaceuticals' future price movements. Getting to know how Eledon Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eledon Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PBYI | Puma Biotechnology | 0.19 | 7 per month | 4.19 | 0.1 | 5.25 | (3.92) | 43.28 | |
| ABEO | Abeona Therapeutics | (0.06) | 24 per month | 3.23 | 0.06 | 6.16 | (5.48) | 26.76 | |
| ALLO | Allogene Therapeutics | 0.05 | 8 per month | 4.11 | 0.13 | 12.38 | (7.48) | 26.97 | |
| VNDA | Vanda Pharmaceuticals | 0.07 | 10 per month | 3.73 | 0.14 | 11.39 | (5.84) | 39.51 | |
| AVIR | Atea Pharmaceuticals | 0.02 | 4 per month | 3.16 | 0.1 | 5.54 | (4.43) | 17.79 | |
| VYGR | Voyager Therapeutics | (0.05) | 7 per month | 0.00 | (0.08) | 4.58 | (5.23) | 19.71 | |
| TRDA | Entrada Therapeutics | 0.19 | 2 per month | 2.62 | 0.18 | 6.65 | (4.08) | 18.48 | |
| HUMA | Humacyte | (0.02) | 8 per month | 0.00 | (0.06) | 8.93 | (8.13) | 21.58 | |
| ACHV | Achieve Life Sciences | (0.05) | 8 per month | 0.00 | (0.04) | 7.19 | (6.18) | 25.05 | |
| EDIT | Editas Medicine | (0.03) | 9 per month | 0.00 | (0.14) | 7.54 | (8.18) | 26.68 |
Other Forecasting Options for Eledon Pharmaceuticals
For every potential investor in Eledon, whether a beginner or expert, Eledon Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eledon Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eledon. Basic forecasting techniques help filter out the noise by identifying Eledon Pharmaceuticals' price trends.Eledon Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eledon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Eledon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eledon Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Eledon Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Eledon Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eledon Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eledon Pharmaceuticals stock market strength indicators, traders can identify Eledon Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 22358.89 | |||
| Daily Balance Of Power | (0.36) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 2.12 | |||
| Day Typical Price | 2.11 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.04) |
Eledon Pharmaceuticals Risk Indicators
The analysis of Eledon Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eledon Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eledon stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.48 | |||
| Standard Deviation | 7.85 | |||
| Variance | 61.63 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Eledon Pharmaceuticals
The number of cover stories for Eledon Pharmaceuticals depends on current market conditions and Eledon Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eledon Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eledon Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Eledon Pharmaceuticals Short Properties
Eledon Pharmaceuticals' future price predictability will typically decrease when Eledon Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Eledon Pharmaceuticals often depends not only on the future outlook of the potential Eledon Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eledon Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.5 M | |
| Cash And Short Term Investments | 140.2 M |
Check out Historical Fundamental Analysis of Eledon Pharmaceuticals to cross-verify your projections. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Will Biotechnology sector continue expanding? Could Eledon diversify its offerings? Factors like these will boost the valuation of Eledon Pharmaceuticals. Projected growth potential of Eledon fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Eledon Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Eledon Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Eledon's accounting equity. The concept of intrinsic value - what Eledon Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Eledon Pharmaceuticals' price substantially above or below its fundamental value.
It's important to distinguish between Eledon Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Eledon Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Eledon Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.